Clinical trial · Observational
Functional Proteins in Polycystic Ovary Syndrome
Assessment of the Concentrations of Functional Proteins as Potential Early Markers of Insulin Resistance in Women With Polycystic Ovary Syndrome
NCT06793098CI-TRIAL-00105809recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The concentration of functional proteins: kisspeptin, ghrelin, zonulin will be measured and compared in women with polycystic ovary syndrome (PCOS) and insulin resistance (IR), in women with PCOS without IR, and in women without PCOS.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| PCOS (Polycystic Ovary Syndrome) | — | UNRESOLVED | — |
| Reproductive Age | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Measurement of ghrelin concentration | Diagnostic Test | — | UNRESOLVED |
| Measurement of kisspeptin concentration | Diagnostic Test | — | UNRESOLVED |
| Measurement of zonulin concentration | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Women with polycystic ovary syndrome (PCOS) and insulin resistance (IR)
- interventionNames
- Diagnostic Test: Measurement of kisspeptin concentration
- Diagnostic Test: Measurement of ghrelin concentration
- Diagnostic Test: Measurement of zonulin concentration
- label
- Women with polycystic ovary syndrome (PCOS) without insulin resistance (IR)
- interventionNames
- Diagnostic Test: Measurement of kisspeptin concentration
- Diagnostic Test: Measurement of ghrelin concentration
- Diagnostic Test: Measurement of zonulin concentration
- label
- Women without PCOS
- interventionNames
- Diagnostic Test: Measurement of kisspeptin concentration
- Diagnostic Test: Measurement of ghrelin concentration
- Diagnostic Test: Measurement of zonulin concentration
Primary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * women aged 18-45 years Exclusion Criteria: * removal of at least one ovary * treated diabetes of any type * diagnosed and treated metabolic diseases * diagnosed and treated autoimmune diseases * diagnosed and treated autoinflammatory diseases
References
Publications (0)
Data not yet available
No reference posted for this study.